Log in

NYSE:RMED - RA Medical Systems Stock Price, Forecast & News

-0.14 (-11.57 %)
(As of 12/10/2019 03:36 AM ET)
Today's Range
Now: $1.07
50-Day Range
MA: $1.44
52-Week Range
Now: $1.07
Volume83,200 shs
Average Volume78,140 shs
Market Capitalization$14.35 million
P/E RatioN/A
Dividend YieldN/A
Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological diseases. The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and disposable catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease. It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light used in the treatment of dermatological skin disorders. The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was founded in 2002 and is headquartered in Carlsbad, California.

Industry, Sector and Symbol

Industry Surgical & medical instruments



Sales & Book Value

Annual Sales$6.26 million
Book Value$5.26 per share


Net Income$-30,830,000.00
Net Margins-797.11%


Market Cap$14.35 million
Next Earnings Date3/12/2020 (Estimated)
OptionableNot Optionable

Receive RMED News and Ratings via Email

Sign-up to receive the latest news and ratings for RMED and its competitors with MarketBeat's FREE daily newsletter.

RA Medical Systems (NYSE:RMED) Frequently Asked Questions

What is RA Medical Systems' stock symbol?

RA Medical Systems trades on the New York Stock Exchange (NYSE) under the ticker symbol "RMED."

How were RA Medical Systems' earnings last quarter?

RA Medical Systems Inc (NYSE:RMED) released its quarterly earnings data on Friday, November, 29th. The company reported ($1.30) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.50) by $0.80. The company had revenue of $1.91 million for the quarter, compared to the consensus estimate of $2.08 million. RA Medical Systems had a negative return on equity of 112.93% and a negative net margin of 797.11%. View RA Medical Systems' Earnings History.

When is RA Medical Systems' next earnings date?

RA Medical Systems is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for RA Medical Systems.

What price target have analysts set for RMED?

4 brokerages have issued 12-month price targets for RA Medical Systems' shares. Their forecasts range from $1.50 to $10.00. On average, they anticipate RA Medical Systems' stock price to reach $4.13 in the next twelve months. This suggests a possible upside of 285.5% from the stock's current price. View Analyst Price Targets for RA Medical Systems.

What is the consensus analysts' recommendation for RA Medical Systems?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for RA Medical Systems in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for RA Medical Systems.

Has RA Medical Systems been receiving favorable news coverage?

Headlines about RMED stock have been trending very negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores closest to five being the most favorable. RA Medical Systems earned a coverage optimism score of -3.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. View News Stories for RA Medical Systems.

Are investors shorting RA Medical Systems?

RA Medical Systems saw a drop in short interest in the month of October. As of October 15th, there was short interest totalling 164,400 shares, a drop of 12.2% from the September 15th total of 187,300 shares. Based on an average trading volume of 101,200 shares, the days-to-cover ratio is presently 1.6 days. Currently, 2.5% of the company's stock are short sold. View RA Medical Systems' Current Options Chain.

Who are some of RA Medical Systems' key competitors?

What other stocks do shareholders of RA Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other RA Medical Systems investors own include Corbus Pharmaceuticals (CRBP), Berkshire Hathaway (BRK.A), Globalstar (GSAT), Pareteum (TEUM), Pareteum (TEUM), Adobe (ADBE), Intel (INTC), AK Steel (AKS), Chevron (CVX) and CarMax (KMX).

Who are RA Medical Systems' key executives?

RA Medical Systems' management team includes the folowing people:
  • Mr. Dean Irwin, CEO, Chief Technology Officer & Chairman of Director (Age 56)
  • Mr. Jeffrey Jay Kraws, Pres (Age 55)
  • Ms. Melissa Burstein, Exec. VP & Director (Age 43)
  • Mr. Richard Heymann, Director of Corp. Strategy & Bus. Devel. (Age 64)
  • Mr. Andrew C. Jackson, Chief Financial Officer (Age 50)

When did RA Medical Systems IPO?

(RMED) raised $50 million in an initial public offering (IPO) on Thursday, September 27th 2018. The company issued 3,300,000 shares at a price of $14.00-$16.00 per share. Piper Jaffray and Cantor served as the underwriters for the IPO and SunTrust Robinson Humphrey, Nomura and Maxim Group were co-managers.

Who are RA Medical Systems' major shareholders?

RA Medical Systems' stock is owned by a variety of of institutional and retail investors. Top institutional investors include Bourne Lent Asset Management Inc. (0.39%) and FNY Investment Advisers LLC (0.32%). Company insiders that own RA Medical Systems stock include Andrew C Jackson, Dean Irwin and Jeffrey J Kraws. View Institutional Ownership Trends for RA Medical Systems.

Which major investors are buying RA Medical Systems stock?

RMED stock was purchased by a variety of institutional investors in the last quarter, including Bourne Lent Asset Management Inc. and FNY Investment Advisers LLC. View Insider Buying and Selling for RA Medical Systems.

How do I buy shares of RA Medical Systems?

Shares of RMED can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is RA Medical Systems' stock price today?

One share of RMED stock can currently be purchased for approximately $1.07.

How big of a company is RA Medical Systems?

RA Medical Systems has a market capitalization of $14.35 million and generates $6.26 million in revenue each year. The company earns $-30,830,000.00 in net income (profit) each year or ($3.34) on an earnings per share basis. RA Medical Systems employs 95 workers across the globe.View Additional Information About RA Medical Systems.

What is RA Medical Systems' official website?

The official website for RA Medical Systems is http://www.ramed.com/.

How can I contact RA Medical Systems?

RA Medical Systems' mailing address is 2070 Las Palmas Drive, Carlsbad CA, 92011. The company can be reached via phone at 760-804-1648 or via email at [email protected]

MarketBeat Community Rating for RA Medical Systems (NYSE RMED)

Community Ranking:  2.0 out of 5 (star star)
Outperform Votes:  55 (Vote Outperform)
Underperform Votes:  82 (Vote Underperform)
Total Votes:  137
MarketBeat's community ratings are surveys of what our community members think about RA Medical Systems and other stocks. Vote "Outperform" if you believe RMED will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RMED will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/10/2019 by MarketBeat.com Staff

Featured Article: P/E Growth (PEG)

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel